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Abstract: Over recent years, a deeper comprehension of the molecular mechanisms that control
biological clocks and circadian rhythms has been achieved. In fact, many studies have contributed to
unravelling the importance of the molecular clock for the regulation of our physiology, including
hormonal and metabolic homeostasis. Here we will review the structure, organisation and molecular
machinery that make our circadian clock work, and its relevance for the proper functioning of
physiological processes. We will also describe the interconnections between circadian rhythms and
endocrine homeostasis, as well as the underlying consequences that circadian dysregulations might
have in the development of several pathologic affections. Finally, we will discuss how a better
knowledge of such relationships might prove helpful in designing new therapeutic approaches for
endocrine and metabolic diseases.
Keywords: circadian clock; central oscillator; peripheral oscillators; hormonal homeostasis; metabolic
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1. Introduction
The idea of the existence in higher organisms of internal rhythms that oscillate autonomously,
synchronising and regulating many biological functions was not easy to accept by the scientific
community. The study of biological rhythms was in fact initially considered with diffidence, and the
concept of an internal self-governing timekeeper, coordinated only by external stimuli such as light,
was difficult to acknowledge. Nonetheless, this topic is now being investigated by an increasing
number of researchers.
Hormonal homeostasis exhibits periodic fluctuations; it is now becoming clear that endocrine
rhythms and circadian rhythms are tightly interconnected, and that the internal clock deeply interacts
with environmental factors to maintain the internal balance.
Here we aimed to review the importance of circadian rhythms, describing how they were discovered
and how their organisation from an anatomical and molecular point of view was brought to light.
Then we will concentrate on the association between circadian clock and hormonal homeostasis,
focusing on the pathophysiological consequences of circadian clock desynchronisation on endocrine
balance and hence on our health.
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2. Circadian Rhythms
2.1. Historical Background
The existence in higher eukaryotes of an internal periodicity, independent of environmental
stimuli was first documented by Jean-Jacques d’Ortous De Mairan at the beginning of the 18th century.
In the leaves of the plant Mimosa pudica, he observed a 24-h periodicity in the opening–closing cycles
that was retained when the plant was kept in the dark. In the middle of 19th century, Alphonse de
Candolle, in the same plant, noticed that the length of the leaf cycle was not precisely 24 h. In the
middle of the 20th century, Erwin Bünning reported that the leaf cycle of Phaseolus coccineus presented
an average periodicity of 24.4 h [1]. In the same years, Colin Pittendrigh and his collaborators found
that likewise, in the fruit fly Drosophila, the daily cycle oscillated between 22 and 28 h [2–4]. These
findings introduced a key concept for the understanding of circadian rhythms: the periodicity is not
provoked by external stimuli, but is “innate”, the average period being about 24 h. Such internal
autonomous oscillations were termed “free-running” rhythms, and external environmental stimuli
are needed to synchronise them. Light is the main “timer” (“Zeitgeber” in German) that regulates the
free-running cycle and synchronises (“entrain”) mammalian internal clocks with the environmental
time. Light modulates retinal inputs at the central nervous system (CNS) level. Such light entrainment
necessitates neither rods nor cones, since retinal ganglion cells innervating the CNS are intrinsically
photosensitive, and depolarise in response to light also in the absence of all synaptic inputs from rods
and cones [5]. Since the sensitivity, spectral tuning and kinetics of the response to the light fit with
those of the photic entrainment, these ganglion cells are now believed to be the primary photoreceptors
for this system [5].
2.2. The “Molecular” Clock
Since those first discoveries, this field of research has significantly developed, and now many
physiological and biochemical aspects of our internal clocks have been clarified.
The experiments that led to the discovery of the localisation of the internal oscillator and to the
clarification of the nature of the physiological mechanisms involved, were performed in mammals.
The first step was determining that rats with lesions in the hypothalamus lost most of their behavioural
periodicity [6,7]. The actual anatomical site of the clock was subsequently associated in rats to
the suprachiasmatic nucleus (SCN), a small group of cells lying in the anterior hypothalamus [8].
The neural connection linking the eye to the SCN was also elucidated in rats, and termed the
“retinohypothalamic tract” (RHT) [9]. Employing rats and golden hamsters, the regulation of internal
periodic behavioural patterns was demonstrated to be an intrinsic property of the SCN, which produces
a periodic rhythmic electrical activity with a rate of around 24 h. Such an electrical oscillation in turn
produces an analogous pattern in the neighbour neurons, but with a phase shift—in nocturnal animals
mainly during the night [10–12].
The molecular characteristics of the circadian clock were identified as a result of a series of
experiments performed employing mutants of Drosophila and mice. The first gene discovered was
called period (Per), since the mutant flies had an altered eclosion time [13]; the protein codified by
this gene (PER), showed rhythmic cycles of synthesis that were well synchronised with the circadian
behaviour of the fly [14]. A complex negative feedback loop model explaining those observations
was suggested after the individuation of three additional proteins: (a) the product of the timeless
(Tim) gene, TIM, discovered in Drosophila [15,16]; (b) CLOCK, whose gene clock was individuated
in mice [17]; and (c) CYCLE (CYC) whose gene cycle was described in Drosophila [18]. In Drosophila,
the regulatory mechanism works through the formation of a CLOCK·CYCLE complex, which binds
to the E-box region on Per and Tim promoters, thus stimulating their transcription. When PER and
TIM level increases, the PER·TIM complex interacts with CLOCK·CYCLE, stopping its function as
a transcriptional activator. When the transcription is blocked, a new cycle of synthesis can begin.
This mechanism is further fine-tuned by the doubletime (DBT) protein kinase, which phosphorylates
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PER, addressing it to proteasomal degradation. DBT is able to phosphorylate PER only when it
is in its free form, but not when it is found complexed with TIM: for such a reason the PER·TIM
complex forms only when there is an increase in the level of TIM, which inside the nucleus is stable for
about 10 h. The light entrainment is achieved by two different light-catching systems, which work
through two distinct photopigments: cryptochrome (CRY), and opsin. After the light has been sensed,
the stimulus leads to TIM degradation, which in turn will reset the whole mechanism [19].
The clock of mice differs in some key aspects if compared with the Drosophila clock. Three Per
homologue genes have been identified so far, namely mPer1–3. Their transcription is quickly activated
by light, with a period of nearly 24 h [20–22]. So far, no evidence supporting the presence of a gene
performing a function equivalent to that of Tim has been found in Drosophila, even if an essential role for
one of these possible analogues in entraining the clock in cooperation with Per1/2 was suggested [23].
Several lines of evidence demonstrate the involvement of Tim in the regulation of developmental
processes, hence substantiating the hypothesis of an important role played by the circadian clock in the
early developmental stages in mammals. In fact, in mouse and rat embryos, Tim is highly expressed in
the developing lung, liver, and kidney, as well as in neuroepithelium, supporting its role in epithelial
organogenesis [24]. Furthermore, Tim regulates the apoptotic processes involved in mouse embryonic
stem cell differentiation [25].
The mammalian analogue of cycle was termed Bmal1 [26]. In mammals, Cry has two isoforms,
Cry1 and Cry2. Even if not playing a direct role in the reception of light, Cry is necessary for the
feedback mechanism [27–29]. Additional players, namely Rev-Erb α/β and ROR α/β, further refine
the mechanism. They interact with the RORE enhancer element in the Bmal1 gene, and repress and
stimulate its transcription respectively [30–33]. Although formerly considered not fundamental for the
generation of circadian rhythmicity, they are now acknowledged to play a significant function [34].
Finally, the mammalian functional analogues of Drosophila DBT are casein kinase 1ε (CK1ε) and casein
kinase 1δ (CK1δ), which, as a complex (CK1δ/ε), phosphorylate PER proteins, directing them to
proteasomal degradation [35,36]. Therefore, in mammals the overall process commences after the light
is detected by both “classical” photoreceptors, and by the photoreceptor melanopsin, which is located
in the retinal ganglion cells that form the RHT tract and project to the SCN [5,37,38]. Light then activates
a chain of responses that in turn reset the clock by increasing mPer1-2 transcription [39–41]. The de novo
synthesised PER proteins, after binding to CRY, enter into the nucleus, where the PER·CRY complex
inhibits the transcription of clock controlled genes (ccg) and of their own genes, whose expression is
typically activated upon the binding of CLOCK·BMAL1 to the E-box enhancer elements [42,43].
As described above, an additional checkpoint is represented by the CK1δ/ε-mediated PER·CRY
phosphorylation, which addresses the complex to proteasomal degradation. It has been proposed
that CLOCK may own histone acetyltransferase (HAT) activity, which increases after the binding of
its heterodimeric partner BMAL1. This HAT activity of CLOCK is fundamental to restore circadian
rhythmicity and the activation of circadian genes in Clock mutant cells [43]. In mouse liver, CLOCK was
also shown to acetylate BMAL1, which underwent rhythmic acetylation with a timing that parallels
the down-regulation of circadian clock-controlled gene transcription. BMAL1 acetylation facilitates
CRY1 recruitment to CLOCK-BMAL1, thus triggering transcriptional repression. Consequently, this
enzymatic interaction between the two clock components is central for the proper functioning of the
circadian mechanism [42,43].
The circadian electric activity produced in the SCN has to be transmitted to the rest of the brain
and then be translated in signals that might be received by the peripheral districts of the body. The SCN
transmits signals in three main ways: (a) neuronal networking, by directly taking contact with several
other brain regions; (b) chemically, by synthesising signalling molecules; and (c) indirectly, by setting
rest-activity rhythms that in turn trigger feeding-fasting cycles, which were shown to represent the
principal Zeitgeber for the synchronisation of the clock of several peripheral organs [44,45]. In fact, the
SCN interacts directly with the subparaventricular zone (sPVZ) [46,47], the preoptic area (POA), the
bed nucleus of the stria terminalis (BNST), the lateral septum (LS), the dorsomedial hypothalamus
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(DMH), the arcuate nucleus (ARC), and the paraventricular nucleus (PVN) [46,47]. The signal is
then conveyed from the SCN to the above-mentioned structures through classical neurotransmission
mediated by GABA and glutamate [48]. The SCN also produces several signal molecules, which
in turn act on adjacent structures. Amongst the best characterised so far are arginine vasopressin
(AVP) [49–51], vasoactive intestinal peptide (VIP) [48], cardiotrophin-like cytokine [52], prokineticin 2
(PK2) [53], epidermal growth factor (EGF) [54] and transforming growth factor α (TGFα) [55].
2.3. Peripheral Clocks
The molecular machinery that controls the circadian activity is expressed not only in the SCN,
but also in almost all the peripheral tissues, as at first shown in rodents [56]. Such peripheral rhythms
are however reliant on the activity of the central pacer, since in vitro they attenuated until blocking
after 2–7 cycles in the liver, lung and skeletal muscle, in the absence of the contribution of the SCN [56].
Following research described that peripheral tissues in isolation were able to self-sustain a circadian
periodicity for more than 20 cycles. Moreover, peripheral organs showed tissue-specific differences
in circadian period and phase, and lesions of the SCN did not reset circadian rhythmicity, but just
desynchronized peripheral tissues of individual animals and from different animals. Therefore,
peripheral organs express at least a partially self-sustained circadian oscillator [57]. Such circadian
behaviour was observed also in vitro in several cell types [58–61], and in tissue explants from almost all
the organs [57,62]. Interestingly, the brain itself possesses its own circadian oscillation in the expression
of several genes that seems to be independent of the activity of the SCN, at least according to what
was shown in the olfactory bulb [63,64].
A comprehensive bioinformatics study performed in mice led to the identification of 41 circadian
genes that oscillated in a circadian way in several mouse tissues with a considerable consistency
of circadian phases in the different tissues. Interestingly, comparisons between mouse, rat, rhesus
macaque, and man revealed that the phase of key circadian genes presented a delay in the other species
if compared to mice (4–5 h in rats, 8–12 h in macaques and humans). Overall, approximately 2%–10%
of the entire genome displayed a circadian pattern of expression in several tissues. Part of such genes
was expressed tissue-specifically; nevertheless, almost all tissues shared the vast majority of them.
The genes involved in the periodicity—such as Per2, Bmal1, Rev-erbα and Cry—presented the higher
degree of conservation [65]. On the other hand, from a study that compared the oscillating transcripts
in mouse liver and NIH3T3 and U2OS cells, it emerged that the number of cycling transcripts in
cellular systems was very different if compared to tissues from intact mice. In particular, two big
gene clusters cycled in the liver, but not in cultured cells. Interestingly, a 12-h oscillatory transcript
rhythm was observed also in other peripheral tissues, including the heart, kidney, and lung. Such
patterns were lost ex vivo and under restricted feeding conditions. This study clearly demonstrated
the presence of circadian harmonic of gene expression in mice, while recommending prudence when
approaching to the study of circadian clock employing cellular models [66].
2.3.1. Entrainment of Peripheral Clocks
Three main sources of entrainment are involved in the synchronisation of peripheral clocks:
(a) direct entrainment by the SCN through neural and hormonal signals; (b) entrainment through
feeding-fasting rhythms; (c) body temperature entrainment.
Neural control is undertaken through the autonomic nervous system, whose outputs are in turn
indirectly controlled by the SCN. The SCN seems to have a multifaceted role in the entrainment of the
different peripheral organs. The extent of the involvement of the SCN in this regulation and which
mechanisms may possibly be involved is still under investigation. It is well-known that damages in the
SCN result in the elimination of circadian patterns of feeding and drinking [8]. In a study performed
in mouse liver, about 9% out of around 2000 genes screened showed an evident circadian cycling
pattern. The circadian regulation of these genes was tissue specific, since the new-identified rhythmic
hepatic genes did not show a rhythmic expression in the brain, even when detected in the SCN.
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Thus, since SCN ablation severely compromised cyclical expression of liver circadian genes, authors
concluded that the circadian rhythmic transcriptome in peripheral organs is strictly SCN-dependent,
but for proper functioning it needs a crosstalk between tissue-specific factors and SCN regulation [67].
In SCN-deficient rats, light did not trigger the sympathetic-induced corticosterone release by the
adrenal gland [68]. Likewise, in rats without the SCN, the hyperglycaemic effect of GABA antagonists
was lost [69]. In rats whose autonomic liver innervation was surgically removed, light could not
induce Per1/2, Pepck and Glut2 up regulation [70]. Interestingly, in rats, fast/feeding schedule and
light cycles contributed to set the phase of clock genes in submaxillary salivary gland. Also, after
SCN sympathetic denervation, Per1 rhythms in submaxillary glands shifted their phase and entrained
to daytime feeding. Hence, authors suggest that peripheral oscillator entrainment may be achieved
through the synergistic action of diverse signals and that the elimination of the dominant SCN signal
may leave the control to a secondary signal [71].
Feeding-fasting rhythms exert a central role for the entrainment of several peripheral organs,
such as the heart, kidney, pancreas and liver. In mouse liver, the vast majority of the genes that
are involved in the regulation of metabolic pathways are expressed in a circadian way [72]. In rats
which feed during the night, the inversion of feeding rhythms—namely the artificial induction of
a diurnal eating—promptly and considerably altered the expression of metabolic genes in the liver;
the rhythmicity was slightly affected also in the lung [73]. In Cry1/2-deficient mice, temporally restricted
feeding restored the circadian transcriptional periodicity of the vast majority of the hepatic genes.
In contrast, in the absence of a fixed feeding schedule, the animals maintained the transcriptional
periodicity of just the minor part of the usual circadian-expressed genes [45]. The regulation of
circadian rhythms in peripheral tissues by feeding/fasting is achieved also by hormones such as
peptide YY, oxyntomodulin, cholecystokinin, leptin, and ghrelin, which directly signal to the arcuate
nucleus (reviewed in [74]).
The third important factor for circadian clock regulation in peripheral tissues is temperature,
even if the mechanisms involved are so far not completely clarified. In mice the SCN is able to
compensate for temperature variations of the external and internal environment; this process seems
to be mediated by CRY and PER. Also, heat-shock factor 1 (HSF1) inhibition mimicked the effect
of cool pulses, while blocking HSF1 induction resulted in a loss of resetting after warm pulses.
Hence, authors suggested a key role of HSF1 pathway in temperature entrainment in mammals [75].
Likewise, it was reported that in cultured fibroblasts from both mice and humans, simulated body
temperature cycles, with daily temperature differences of 3 ◦C and 1 ◦C respectively, were able to
synchronize circadian gene expression. After few days, gene expression was actually synchronized
with temperature cycles, and such temperature rhythms also entrained gene expression cycles to
periods longer or shorter than 24 h. Interestingly, HSF1 but not HSF2, was needed for fibroblast
oscillator synchronization to simulated body temperature cycles. Thus, the authors suggested a model
according to which in peripheral cell types elevated temperatures induce HSF1 activity, which, in
cooperation with other temperature-sensitive regulators, promote the expression of immediate early
genes (IEGs) such as Per2. In turn, IEGs may phase-reset other clock genes such as Bmal1. Authors also
do not exclude a direct action of temperature on clock protein activity and stability [76]. Thus, working
synergistically to orchestrate the circadian phase, light and temperature modulate the regulation of the
clock, contributing to the seasonal adaptations of clock functions.
2.3.2. Liver and Pancreas Clocks
The level of expression of many hepatic genes, both clock-related and hepatic-specific, follows a
circadian periodicity. Circadian genes play a complex role for liver functions. Bmal1-deficient mice
lost the rhythmic behaviour in both the brain and the liver, while Clock-deficient mice showed a not
functional hepatic circadian clock but preserved central periodicity [77]. Nonetheless, liver periodicity
shows a relative autonomy from the central regulator. In mice, the glucocorticoid receptor rescued
about 60% of circadian gene expression that was lost by damaging the SCN [78]. Food also plays a
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key role, even when the central pacemaker is correctly working, since more than 80% of the hepatic
transcriptome is “meal-dependent” [73].
The circadian oscillator plays a fundamental role in the regulation of glucose metabolism.
In Bmal1- and Per1/2-deficient mice, liver-specific Bmal1 inactivation resulted in severe hypoglycaemia
during the inactivity period, but not if Bmal1 was inactivated in the other entire cell types excluding
the liver [77]. A recent study showed that Per2 controls glucose homeostasis in humans as well [79].
In mice, bile acid and cholesterol biosynthesis regulation is under circadian control through
Rev-Erbα, which governs SREBP expression, and thus that of cholesterol metabolism genes. It was
also proposed that the cyclic expression of cholesterol-7α-hydroxylase (Cyp7a1) might be driven by a
REV-ERBα-mediated mechanism, by means of an oxysterol-mediated LXR activation [80].
The existence of an independent circadian oscillator in the pancreas was recently demonstrated.
Bmal1 and Clock play a key role, since their selective knockdown in mice led to modifications of the
proliferative rate and size of islet cells, together with hypoinsulinaemia, reduced glucose tolerance and
diabetes [81,82].
3. Circadian Clock in Hormonal Homeostasis
Several hormones were shown to have daily oscillations, and among these the best characterised
are melatonin, cortisol, gonadal steroids, prolactin, thyroid hormone and growth hormone (GH).
The so-called nutrient-sensitive hormones, namely insulin, leptin, ghrelin and adiponectin also oscillate
on a circadian basis, and their release is, at least in part, regulated by environmental stimuli, such as
feeding time and light–dark cycles.
3.1. SCN as a Controller of Endocrine Homeostasis
3.1.1. Melatonin
SCN directly interacts with the pineal gland through the sympathetic neurons of the superior
cervical ganglion [83]; in turn, the rhythmic activity of the SCN determines the release of melatonin,
which directly correlates with day length. In both nocturnal and diurnal animals, melatonin production
peaks in the middle of the night, between 24:00 and 03:00, inducing activity in the former and rest/sleep
in the latter.
Melatonin plays several key roles, and can be considered the central “relayer” which conveys
information about light–dark cycles. In mammals, melatonin is also essential in the regulation of
reproductive behaviour and sleep.
Melatonin functions as a feedback regulator on SCN. Melatonin receptors MT1 and MT2 are
expressed at high densities in SCN [84]. In rats kept in the dark and in blind humans, melatonin
entrained the free-running rhythm [85–90]. in vitro, melatonin also regulated the phase and amplitude
of the electric circadian activity of SCN explants [91,92]. MT2 receptor was shown to mediate the
phase-synchronising effect of melatonin on SCN [93].
Interestingly, in both primates and humans, melatonin modulates adrenal glucocorticoid
production, being able to suppress cortisol production [94–96]. This effect is mediated by MT1
receptor [96]. Such effects were also observed in foetal rats, where melatonin entrained adrenal
gland secretion rhythms [97]. The secretion of several hormones, namely gonadotropin-releasing
hormone (GnRH), luteinising hormone (LH), and follicle-stimulating hormone (FSH) is likewise under
melatonin control [98]. Melatonin is also synthesized in peripheral tissues, such as the gastrointestinal
tract, the retina, skin, lymphocytes and bone marrow, from which it may in turn modulate other
physiological functions through paracrine signalling.
After its discovery, many hypotheses have been proposed about the factual role of melatonin for
the regulation of biological functions [99]. In fact, melatonin was shown to affect several physiological
functions, such as blood pressure regulation [100], immune system modulation and free radical
scavenging [98]. In addition to its well-known role as a circadian clock pacer, melatonin was also
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suggested to positively affect mood disorders as well as cardiovascular, gastrointestinal and bone
physiology. Also, melatonin was addressed in playing a role as an oncostatic molecule [98], even
if more clinical trials will be necessary to ascertain its possible future role in tumour therapy [101].
In fact, some reports underlined that the evidence gathered so far is inconclusive and not sufficient to
corroborate such a view [102,103].
3.1.2. Vasopressin, Acetylcholine, Adrenocorticotropic Hormone
The circadian activity of the SCN directly influences the rhythmic secretion of several other
hormones. Arginine vasopressin (AVP), or simply vasopressin, is produced in paraventricular (PVN)
and supraoptic (SON) nuclei of the hypothalamus and transported to the posterior pituitary, whence it
is released in the system circulation, reducing water elimination from kidneys to prevent dehydration.
The SCN directly regulates AVP secretion into the cerebrospinal fluid; as a SCN neurotransmitter,
AVP is also essential as an autocrine regulator and pacer of the neuronal activity [50,104].
The neurotransmitter acetylcholine (ACh) was one of the first neurotransmitters suggested to
be involved in circadian rhythmicity and actually, it shows a circadian pattern of release, which
is high during the active phase [105,106]. Despite of this, the evidence collected so far is not
conclusive. The cholinergic system in mammals (men included) shows a marked circadian activity.
ACh is released during wakefulness and motor activity, whereas a reduced release is observed
during sleep. It was hence speculated that behavioural activity patterns, circadian rhythms, and
cholinergic neurotransmission were tightly coupled. Several studies have indeed demonstrated a
role of cholinergic signalling in the regulation and maintenance of circadian rhythms via nicotinic
and muscarinic acetylcholine receptors (nAChRs and mAChRs, respectively) [106]. In any case,
further investigations will be necessary to more deeply clarify the role of ACh in the regulation of
circadian rhythms.
The SCN coordinates also the periodic release of glucocorticoids from the adrenal cortex [107],
which results in the maximal production in the early morning for diurnal animals, and in the early
evening for nocturnal ones [108,109]. Adrenocorticotropic hormone (ACTH), which induces the release
of corticosterone from the adrenal cortex, shows a similar pattern of release from the corticotrope
cells of the pituitary [108–110]. Such a process is repressed by light, and it seems to be directly
dependent on SCN through its connections to the paraventricular nucleus [108–110]. Such precise
control is crucial considering the key functions performed by this hormone, both as a precursor of
aldosterone and for the regulation of hepatic metabolism [111]. Of note, the glucocorticoid receptor
agonist dexamethasone synchronises circadian gene expression in rat fibroblasts and shifts the phase of
expression of circadian genes in the liver, kidney, and heart. Due to the lack of glucocorticoid receptors
in the SCN, dexamethasone does not modify its circadian behaviour [78,112].
3.1.3. Cortisol
Among all glucocorticoid hormones, cortisol is one of the best characterised from a circadian
point of view. In humans, cortisol production usually increases during the night and shows a peak of
secretion in the morning, around 07:00–08:00, in this way setting the endocrine balance for the stress
associated with waking [113,114].
Jet lag and sleep desynchronisation were shown to increase cortisol levels in humans [115,116],
and increased cortisol was associated with several pathologies such as cardiometabolic diseases, sleep
and mood disorders, [117] and tumours [118,119].
Glucocorticoids and cortisol can modulate the expression of clock-controlled genes in the liver,
kidney and adipose tissues [120,121]. Moreover, in a mouse model of jet lag, glucocorticoids were
identified as key modulators for clock resynchronisation [122]. Interestingly, it was recently reported
that in rats, clock genes showed their usual circadian rhythms after adrenalectomy and feeding/fasting
rhythm disruption, even if the hepatic neuronal inputs were maintained. These data underline the
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importance of fasting/feeding cycles and of adrenal hormones for a proper synchronization of the
hepatic clock with the SCN [123].
3.1.4. Insulin and Ghrelin
Insulin and ghrelin represent two key factors in metabolic regulation, and now several circadian
factors are recognised to regulate their secretion and activity.
In humans, insulin secretion shows a zenith at around 17:00 and a nadir at about 04:00, thus
promoting nutrient storage in the active phase. The clock tightly controls insulin secretion, since
deficiency in both CLOCK and BMAL1 determines hypoinsulinaemia [81,82], whereas loss of PER and
CRY causes hyperinsulinaemia [124,125]. Shift work was shown to determine a rise in insulin secretion
together with a decrease in insulin sensitivity, possibly implying a pre-diabetic condition [126,127].
Insulin and glucose are also able to control the clock. In a three-dimensional rat hepatocyte model and
in primary mouse hepatocytes, insulin resynchronised the liver clock [128,129]. Moreover, glucose was
shown to down-regulate Per1 and Per2 expression in cultured rat fibroblasts [130].
The oxyntic cells of the stomach secrete ghrelin before feeding time, independently from light,
according to their own circadian clock [131]. The main action of ghrelin is appetite stimulation [132–134].
It was shown that in shift workers the normal ghrelin cycle was disrupted, possibly explaining the
observed overfeeding [135]. In mice, ghrelin also directly regulated the expression of clock genes in
the SCN, increasing food intake [136].
3.1.5. Adiponectin and Leptin
Adiponectin is a so-called adipokine, since it is secreted by adipose tissue. In humans, its
peak of production is observed between 12:00 and 14:00 [137,138]. Adiponectin is known as an
anti-inflammatory and insulin-sensitizer molecule [139]; its level was inversely correlated with obesity,
and decreased weight results in its increase [140,141]. In rodents under high-fat diet (HFD), an inverse
correlation was demonstrated between fat mass and adiponectin levels [142,143]. In a mouse model
of metabolic syndrome with hypoadiponectinemia, animals showed a reduced circadian locomotor
activity, but an increased activity during the light-phase. Also, circadian gene expression was shifted
in the liver and skeletal muscle. Restoring the adiponectin gene expression in the liver resulted in the
recovery of the correct locomotor activity pattern, together with hepatic clock gene expression [144].
Leptin is secreted by the white adipose tissue after the hepatic glucose level increases, and acting
at the level of the appetite centres in the hypothalamus, it conveys signals of satiety, preventing
overfeeding. In humans, leptin levels peak during the night. In humans, HFD lowers leptin levels,
while increased fat mass and obesity results in hyperleptinaemia [145]. In female mice, leptin increased
Per expression in the SCN, increasing light phase-shifting action [146]. In rats, ex vivo, leptin was
shown to reset SCN clock phase [147].
4. Circadian Clock and Metabolism Regulation
In the last two decades the comprehension of the influence of circadian clock on metabolism
regulation has greatly improved [148–150].
A central role was attributed to SIRT1, a member of SIRT deacetylase family, whose activation
has been related with many positive effects [151]. SIRT1 activity requires the presence of NAD+ as a
cofactor, consequently, during fasting, when NAD+ level is elevated, SIRT1 activity is high [151]. SIRT1
modulates the rhythmic expression of numerous circadian controlled genes. NAD+-dependent histone
deacetylation mediated by SIRT1 of BMAL1 and PER2 enabled the establishment of a repressive
chromatin state [152]. SIRT1 binds with CLOCK and is recruited at the CLOCK·BMAL1 chromatin
complex at circadian promoters. Genetic disruption of Sirt1 or pharmacological inhibition of SIRT1
desynchronised the circadian cycle: so SIRT1 might play a role as a controller of the circadian
machinery, perceiving modifications in cellular metabolite level [153]. Of note, intracellular NAD+
levels exhibited circadian oscillations, as a consequence of the circadian expression of nicotinamide
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phosphoribosyltransferase (NAMPT) mediated by CLOCK·BMAL1. SIRT1 is then recruited to the
Nampt promoter, directing the synthesis of its own coenzyme [154]. SIRT1 is also involved in
the regulation of circadian transcription of numerous clock genes, namely Bmal1, Per2, Cry1, and
Rorγ. SIRT1 binds CLOCK·BMAL1 and promotes PER2 deacetylation and degradation. Because its
deacetylase activity is dependent upon NAD+ levels, SIRT1 may function as a connector between
cellular metabolism and the circadian machinery [155]. Interestingly, it was shown that SIRT1
stimulates Bmal1 and Clock transcription in the brain, by activating a positive feedback loop involving
SIRT1, PGC-1α, and NAMPT. Aged mice showed decreased SIRT1, BMAL1 and PER2 levels in the
SCN, resulting in a deregulated activity pattern and light entrainment. These effects were not observed
in SCN SIRT1-overexpressing mice [156].
AMPK is a multi-protein complex that plays a central role in metabolism regulation as a general
stimulator of catabolic pathways and inhibitor of anabolic ones. One of its regulatory subunits, ampkβ2,
is expressed in a circadian way, which results in a periodic translocation into the nucleus, where it
directly phosphorylates CRY1 in association with LKB kinase. This phosphorylation determines CRY1
proteasomal degradation [157].
BMAL1 and CLOCK are very important for glucose and triglyceride homeostasis regulation.
Gluconeogenesis was in fact stopped by Bmal1 deletion and reduced in Clock mutants. Furthermore,
high-fat diet amplified circadian oscillations in insulin sensitivity and glucose tolerance [158].
The circadian clock also supervises hepatic gluconeogenesis, which during fasting is started by
the cAMP-mediated phosphorylation of cAMP response element-binding protein (CREB). CREB
activity is regulated during fasting by Cry1 and Cry2. Cry1 expression is high during the night–day
transition, when it reduces fasting gluconeogenic gene expression by inhibiting glucagon-mediated
increase in intracellular cAMP concentrations and protein kinase A-mediated phosphorylation of
CREB. As hepatic overexpression of Cry1 lowers blood glucose concentrations and improves insulin
sensitivity in insulin-resistant mice, molecular cryptochrome activity enhancers might be considered
as useful therapeutic agents for type 2 diabetes [159].
The association between circadian clock and metabolism was further substantiated by the
discovery that the highly metabolically controlled transcription factor REV-ERBα is central for circadian
clock synchronisation [160]. Synthetic REV-ERBα agonists were in fact suggested as positive regulators
for metabolic diseases. In mice treated with synthetic REV-ERB agonists, the circadian expression of
metabolic genes in the liver, skeletal muscle and adipose tissue was modified, leading to augmented
energy expenditure. In fact, diet-induced obese mice treated with REV-ERB agonists showed decreased
fat mass and improved hyperglycaemia and dyslipidaemia [161].
Additional points of contact between circadian clock and metabolism, and in particular with
the development of metabolic diseases were found. For example, the activity of the stomach
ghrelin-secreting cells is synchronised by food through a clock-driven mechanism [131]. Of note,
glycogen synthase kinase-3 (GSK-3β) inhibition resulted in a period shortening of the clock [162].
5. Health Consequences of Circadian Misalignment
Several pathologic affections have been associated with deregulations and disruptions of
circadian rhythms.
In rodent models, experimental jet lag approaches with long-term light-dark shifts, resulted
in reduced body temperature, increased adiposity, altered immune response and tumour
development [163–166]. Forced desynchronisation of light–dark cycles also resulted in perturbed
hormonal homeostasis [122,167,168].
In humans, induced sleep–wake misalignment caused an unscheduled secretion of insulin, leptin
and norepinephrine, whereas cortisol, epinephrine and glucose kept a normal circadian secretion
pattern [169]. Circadian misalignment induced by sleep deprivation increased markers of insulin
resistance and inflammation [170].
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6. Possible Circadian-Based Therapeutic Approaches
It is now clear how much our biological clock is deeply interconnected with our endocrine
homeostasis, and how perturbations of our hormonal balance can result in pathologic consequences.
Hence, finding new therapeutic approaches to cope with the increased incidence of circadian-related
affections might prove essential in the next years.
Many genetic approaches have been suggested which involve direct actions on clock genes,
together with behavioural techniques aiming to change wrong eating and sleeping attitudes. It is
anyway easy to understand that such kinds of approaches are difficult to be performed. In this light,
the development of new molecules targeting clock protein might prove useful. So far, several agents
have been discovered that may work in this sense:
KL001. This molecule stabilises CLOCK protein in vitro, in this way increasing the length of the clock
period. KL001 also decreases hepatic glucose production [171].
SR9009 and
SR9011.
These molecules are REV-ERBα agonists, and were shown to decrease Cry2 rhythms, to
increase Per2 rhythms and to shift Bmal1 ones. SR009 was also effective in decreasing adiposity
and in improving dyslipidaemia and hyperglycaemia in a mouse obesity model [161].
Longdaysin. This molecule was shown to increase circadian period both in vitro and in vivo by inducing
PER1 degradation through the modulation of several kinases, and in particular CKIα [172].
Finally, it is worth mentioning two approaches that are becoming quite popular for the treatment
of circadian and circadian-related disorders: light therapy and chronotherapy.
In the last years a large part of the general population has modified the sleeping schedule during
the weekends in comparison to working days, leading to the so-called “social jetlag”, which was
associated with negative consequences for health. Light therapy in the morning was suggested as
the most effective approach to advance the circadian rhythm and sleep phase. In a recent study it
was demonstrated that short (30 min) blue light pulses in the morning restored sleep integrity and
improved performance impairment. Interestingly, the effect was not observed when using the amber
light [173]. Another very recent report demonstrated that in a small human clinical trial, intermittent
light was more effective than continuous light in shifting circadian phase. Authors showed that there
is an optimal interstimulus interval between the flashes where light flashes were around 2-fold more
effective in phase delaying the circadian system when compared to continuous light exposure about
4000 times longer the duration of the most effective stimulus. Light pulses did not affect melatonin
levels or alertness [174].
Chronotherapy may be defined as the approach employed to maximise the efficacy and minimise
the side effects of a drug treatment by administering it taking into account circadian rhythms.
So far, chronotherapy has been considered and tested for several different types of diseases, such as
hypertension [175–179], rheumatoid arthritis [180], inflammatory diseases [181,182] depression [183]
and tumours [184,185]. Even if convincing evidence has been reported with respect to the efficacy
of such approaches, more clinical trials will be necessary to fully unravel their actual biological and
therapeutic practical relevance.
7. Conclusions
Circadian rhythms are now acknowledged as vital constituents of the multifaceted physiological
machinery that controls and regulates many essential physiological mechanisms in most organisms,
from cyanobacteria to mammals. The strong association between the circadian clock, hormonal
homeostasis and energy metabolism has been brought to light during the last two decades, showing
the role of the central clock in the coordination of the clocks in the peripheral organs. So far, numerous
genes involved in metabolism control have been discovered to be under circadian regulation; therefore,
any modification of this delicate equilibrium often results in the development of severe pathological
conditions. Several points are, in any case, still under investigation, and potential new breakthroughs
will be beneficial not only to increase scientific knowledge, but also to improve public health.
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In fact, in the last years, an increasing portion of the general population modified the lifestyle often
resulting in a decrease and a worse quality of the sleep. Shift work and/or frequent transmeridian
flights have also become more common. Circadian rhythm disruption was in fact associated to an
increased incidence of metabolic, endocrine, cardiovascular, and tumour diseases. It is, in any case,
difficult to ascertain the actual relative contribution of circadian disruption to the onset of such diseases,
since bad habits, such as smoking, alcohol consumption or reduced physical activity might have arisen
as secondary consequences of shift work or frequent transmeridian flights. The picture is indeed
complex and intricate and more research is required for it to be fully untangled.
In this light, new public health policies aimed at making larger portions of the population aware
of the risks of an unscheduled lifestyle, together with the discovery of new drugs that may interact
with the clock molecular machinery, might prove helpful in coping with the new growing pandemic in
metabolic pathologies. In addition, approaches like light therapy and chronotherapy may result useful
in such a perspective.
Author Contributions: Davide Gnocchi conceived and wrote the paper; Giovannella Bruscalupi wrote and
revised the paper.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Bunning, E.; Moser, I. Light-induced phase shifts of circadian leaf movements of phaseolus: Comparison
with the effects of potassium and of ethyl alcohol. Proc. Natl. Acad. Sci. USA 1973, 70, 3387–3389. [CrossRef]
[PubMed]
2. Pittendrigh, C.S. Circadian systems. I. The driving oscillation and its assay in Drosophila pseudoobscura.
Proc. Natl. Acad. Sci. USA 1967, 58, 1762–1767. [CrossRef] [PubMed]
3. Pittendrigh, C.S.; Skopik, S.D. Circadian systems. V. The driving oscillation and the temporal sequence of
development. Proc. Natl. Acad. Sci. USA 1970, 65, 500–507. [CrossRef] [PubMed]
4. Skopik, S.D.; Pittendrigh, C.S. Circadian systems, II. The oscillation in the individual Drosophila pupa; its
independence of developmental stage. Proc. Natl. Acad. Sci. USA 1967, 58, 1862–1869. [CrossRef] [PubMed]
5. Berson, D.M.; Dunn, F.A.; Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock.
Science 2002, 295, 1070–1073. [CrossRef] [PubMed]
6. Richter, C.P. Sleep and activity: Their relation to the 24-hour clock. Res. Publ. Assoc. Res. Nerv. Ment. Dis.
1967, 45, 8–29. [PubMed]
7. Richter, C.P. Inborn nature of the rat’s 24-hour clock. J. Comp. Physiol. Psychol. 1971, 75, 1–4. [CrossRef]
[PubMed]
8. Stephan, F.K.; Zucker, I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated
by hypothalamic lesions. Proc. Natl. Acad. Sci. USA 1972, 69, 1583–1586. [CrossRef] [PubMed]
9. Moore, R.Y.; Eichler, V.B. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions
in the rat. Brain Res. 1972, 42, 201–206. [CrossRef]
10. Inouye, S.T.; Kawamura, H. Persistence of circadian rhythmicity in a mammalian hypothalamic “island”
containing the suprachiasmatic nucleus. Proc. Natl. Acad. Sci. USA 1979, 76, 5962–5966. [CrossRef] [PubMed]
11. Ralph, M.R.; Foster, R.G.; Davis, F.C.; Menaker, M. Transplanted suprachiasmatic nucleus determines
circadian period. Science 1990, 247, 975–978. [CrossRef] [PubMed]
12. Ralph, M.R.; Menaker, M. A mutation of the circadian system in golden hamsters. Science 1988, 241,
1225–1227. [CrossRef] [PubMed]
13. Konopka, R.J.; Benzer, S. Clock mutants of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 1971, 68,
2112–2116. [CrossRef] [PubMed]
14. Siwicki, K.K.; Eastman, C.; Petersen, G.; Rosbash, M.; Hall, J.C. Antibodies to the period gene product of
Drosophila reveal diverse tissue distribution and rhythmic changes in the visual system. Neuron 1988, 1,
141–150. [CrossRef]
15. Hardin, P.E.; Hall, J.C.; Rosbash, M. Feedback of the Drosophila period gene product on circadian cycling of
its messenger RNA levels. Nature 1990, 343, 536–540. [CrossRef] [PubMed]
Biology 2017, 6, 10 12 of 20
16. Sehgal, A.; Rothenfluh-Hilfiker, A.; Hunter-Ensor, M.; Chen, Y.; Myers, M.P.; Young, M.W. Rhythmic
expression of timeless: A basis for promoting circadian cycles in period gene autoregulation. Science 1995,
270, 808–810. [CrossRef] [PubMed]
17. Vitaterna, M.H.; King, D.P.; Chang, A.M.; Kornhauser, J.M.; Lowrey, P.L.; McDonald, J.D.; Dove, W.F.;
Pinto, L.H.; Turek, F.W.; Takahashi, J.S. Mutagenesis and mapping of a mouse gene, Clock, essential for
circadian behavior. Science 1994, 264, 719–725. [CrossRef] [PubMed]
18. Rutila, J.E.; Suri, V.; Le, M.; So, W.V.; Rosbash, M.; Hall, J.C. CYCLE is a second bHLH-PAS clock protein
essential for circadian rhythmicity and transcription of Drosophila period and timeless. Cell 1998, 93, 805–814.
[CrossRef]
19. Veleri, S.; Brandes, C.; Helfrich-Förster, C.; Hall, J.C.; Stanewsky, R. A self-sustaining, light-entrainable
circadian oscillator in the Drosophila brain. Curr. Biol. 2003, 13, 1758–1767. [CrossRef] [PubMed]
20. Shigeyoshi, Y.; Taguchi, K.; Yamamoto, S.; Takekida, S.; Yan, L.; Tei, H.; Moriya, T.; Shibata, S.; Loros, J.J.;
Dunlap, J.C.; Okamura, H. Light-induced resetting of a mammalian circadian clock is associated with rapid
induction of the mPer1 transcript. Cell 1997, 91, 1043–1053. [CrossRef]
21. Tei, H.; Okamura, H.; Shigeyoshi, Y.; Fukuhara, C.; Ozawa, R.; Hirose, M.; Sakaki, Y. Circadian oscillation of
a mammalian homologue of the Drosophila period gene. Nature 1997, 389, 512–516. [CrossRef] [PubMed]
22. Zylka, M.J.; Shearman, L.P.; Weaver, D.R.; Reppert, S.M. Three period homologs in mammals: Differential
light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron
1998, 20, 1103–1110. [CrossRef]
23. Barnes, J.W.; Tischkau, S.A.; Barnes, J.A.; Mitchell, J.W.; Burgoon, P.W.; Hickok, J.R.; Gillette, M.U.
Requirement of mammalian Timeless for circadian rhythmicity. Science 2003, 302, 439–442. [CrossRef]
[PubMed]
24. Li, Z.; Stuart, R.O.; Qiao, J.; Pavlova, A.; Bush, K.T.; Pohl, M.; Sakurai, H.; Nigam, S.K. A role for Timeless in
epithelial morphogenesis during kidney development. Proc. Natl. Acad. Sci. USA 2000, 97, 10038–10043.
[CrossRef] [PubMed]
25. O’Reilly, L.P.; Watkins, S.C.; Smithgall, T.E. An unexpected role for the clock protein timeless in
developmental apoptosis. PLoS ONE 2011, 6, e17157. [CrossRef] [PubMed]
26. Gekakis, N.; Staknis, D.; Nguyen, H.B.; Davis, F.C.; Wilsbacher, L.D.; King, D.P.; Takahashi, J.S.; Weitz, C.J.
Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280, 1564–1569. [CrossRef]
[PubMed]
27. Thresher, R.J.; Vitaterna, M.H.; Miyamoto, Y.; Kazantsev, A.; Hsu, D.S.; Petit, C.; Selby, C.P.; Dawut, L.;
Smithies, O.; Takahashi, J.S.; Sancar, A. Role of mouse cryptochrome blue-light photoreceptor in circadian
photoresponses. Science 1998, 282, 1490–1494. [CrossRef] [PubMed]
28. Van der Horst, G.T.; Muijtjens, M.; Kobayashi, K.; Takano, R.; Kanno, S.; Takao, M.; de Wit, J.; Verkerk, A.;
Eker, A.P.; van Leenen, D.; Buijs, R.; et al. Mammalian Cry1 and Cry2 are essential for maintenance of
circadian rhythms. Nature 1999, 398, 627–630. [PubMed]
29. Vitaterna, M.H.; Selby, C.P.; Todo, T.; Niwa, H.; Thompson, C.; Fruechte, E.M.; Hitomi, K.; Thresher, R.J.;
Ishikawa, T.; Miyazaki, J.; et al. Differential regulation of mammalian period genes and circadian rhythmicity
by cryptochromes 1 and 2. Proc. Natl. Acad. Sci. USA 1999, 96, 12114–12119. [CrossRef] [PubMed]
30. Guillaumond, F.; Dardente, H.; Giguère, V.; Cermakian, N. Differential control of Bmal1 circadian
transcription by REV-ERB and ROR nuclear receptors. J. Biol. Rhythm. 2005, 20, 391–403. [CrossRef]
[PubMed]
31. Liu, A.C.; Tran, H.G.; Zhang, E.E.; Priest, A.A.; Welsh, D.K.; Kay, S.A. Redundant function of REV-ERBalpha
and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian
rhythms. PLoS Genet. 2008, 4, e1000023. [CrossRef] [PubMed]
32. Preitner, N.; Damiola, F.; Lopez-Molina, L.; Zakany, J.; Duboule, D.; Albrecht, U.; Schibler, U. The orphan
nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian
circadian oscillator. Cell 2002, 110, 251–260. [CrossRef]
33. Sato, T.K.; Panda, S.; Miraglia, L.J.; Reyes, T.M.; Rudic, R.D.; McNamara, P.; Naik, K.A.; FitzGerald, G.A.;
Kay, S.A.; Hogenesch, J.B. A functional genomics strategy reveals Rora as a component of the mammalian
circadian clock. Neuron 2004, 43, 527–537. [CrossRef] [PubMed]
Biology 2017, 6, 10 13 of 20
34. Cho, H.; Zhao, X.; Hatori, M.; Yu, RT.; Barish, G.D.; Lam, M.T.; Chong, L.W.; DiTacchio, L.; Atkins, A.R.;
Glass, C.K.; et al. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta.
Nature 2012, 485, 123–127. [CrossRef] [PubMed]
35. Camacho, F.; Cilio, M.; Guo, Y.; Virshup, D.M.; Patel, K.; Khorkova, O.; Styren, S.; Morse, B.; Yao, Z.;
Keesler, G.A. Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2.
FEBS Lett. 2001, 489, 159–165. [CrossRef]
36. Eide, E.J.; Woolf, M.F.; Kang, H.; Woolf, P.; Hurst, W.; Camacho, F.; Vielhaber, E.L.; Giovanni, A.; Virshup, D.M.
Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation.
Mol. Cell. Biol. 2005, 25, 2795–2807. [CrossRef] [PubMed]
37. Hattar, S.; Liao, H.W.; Takao, M.; Berson, D.M.; Yau, K.W. Melanopsin-containing retinal ganglion cells:
Architecture, projections, and intrinsic photosensitivity. Science 2002, 295, 1065–1070. [CrossRef] [PubMed]
38. Hattar, S.; Lucas, R.J.; Mrosovsky, N.; Thompson, S.; Douglas, R.H.; Hankins, M.W.; Lem, J.; Biel, M.;
Hofmann, F.; Foster, R.G.; et al. Melanopsin and rod-cone photoreceptive systems account for all major
accessory visual functions in mice. Nature 2003, 424, 76–81. [CrossRef] [PubMed]
39. Albrecht, U.; Zheng, B.; Larkin, D.; Sun, Z.S.; Lee, C.C. mPer1 and mPer2 are essential for normal resetting of
the circadian clock. J. Biol. Rhythm. 2001, 16, 100–104. [CrossRef]
40. Bae, K.; Jin, X.; Maywood, E.S.; Hastings, M.H.; Reppert, S.M.; Weaver, D.R. Differential functions of mPer1,
mPer2, and mPer3 in the SCN circadian clock. Neuron 2001, 30, 525–536. [CrossRef]
41. Zheng, B.; Albrecht, U.; Kaasik, K.; Sage, M.; Lu, W.; Vaishnav, S.; Li, Q.; Sun, Z.S.; Eichele, G.; Bradley, A.;
et al. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001, 105,
683–694. [CrossRef]
42. Doi, M.; Hirayama, J.; Sassone-Corsi, P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006,
125, 497–508. [CrossRef] [PubMed]
43. Hirayama, J.; Sahar, S.; Grimaldi, B.; Tamaru, T.; Takamatsu, K.; Nakahata, Y.; Sassone-Corsi, P.
CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature 2007, 450, 1086–1090. [CrossRef]
[PubMed]
44. Damiola, F.; Le Minh, N.; Preitner, N.; Kornmann, B.; Fleury-Olela, F.; Schibler, U. Restricted feeding
uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic
nucleus. Genes Dev. 2000, 14, 2950–2961. [CrossRef] [PubMed]
45. Stokkan, K.A.; Yamazaki, S.; Tei, H.; Sakaki, Y.; Menaker, M. Entrainment of the circadian clock in the liver
by feeding. Science 2001, 291, 490–493. [CrossRef] [PubMed]
46. Leak, R.K.; Card, J.P.; Moore, R.Y. Suprachiasmatic pacemaker organization analyzed by viral transynaptic
transport. Brain Res. 1999, 819, 23–32. [CrossRef]
47. Schwartz, M.D.; Urbanski, H.F.; Nunez, A.A.; Smale, L. Projections of the suprachiasmatic nucleus and
ventral subparaventricular zone in the Nile grass rat (Arvicanthis niloticus). Brain Res. 2011, 1367, 146–161.
[CrossRef] [PubMed]
48. Hermes, M.L.; Coderre, E.M.; Buijs, RM.; Renaud, L.P. GABA and glutamate mediate rapid neurotransmission
from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat. J. Physiol. 1996, 496 Pt 3,
749–757. [CrossRef] [PubMed]
49. Kalsbeek, A.; Buijs, R.M. Peptidergic transmitters of the suprachiasmatic nuclei and the control of circadian
rhythmicity. Prog. Brain Res. 1992, 92, 321–333. [PubMed]
50. Kalsbeek, A.; Buijs, R.M.; Engelmann, M.; Wotjak, C.T.; Landgraf, R. In vivo measurement of a diurnal
variation in vasopressin release in the rat suprachiasmatic nucleus. Brain Res. 1995, 682, 75–82. [CrossRef]
51. Kalsbeek, A.; Buijs, R.M.; van Heerikhuize, J.J.; Arts, M.; van der Woude, T.P. Vasopressin-containing neurons
of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 1992, 580, 62–67. [CrossRef]
52. Kraves, S.; Weitz, C.J. A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor
activity. Nat. Neurosci. 2006, 9, 212–219. [CrossRef] [PubMed]
53. Cheng, M.Y.; Bullock, C.M.; Li, C.; Lee, A.G.; Bermak, J.C.; Belluzzi, J.; Weaver, D.R.; Leslie, F.M.; Zhou, Q.Y.
Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417,
405–410. [CrossRef] [PubMed]
54. Kramer, A.; Yang, F.C.; Snodgrass, P.; Li, X.; Scammell, T.E.; Davis, F.C.; Weitz, C.J. Regulation of daily
locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 2001, 294, 2511–2515.
[CrossRef] [PubMed]
Biology 2017, 6, 10 14 of 20
55. Li, X.; Sankrithi, N.; Davis, F.C. Transforming growth factor-alpha is expressed in astrocytes of the
suprachiasmatic nucleus in hamster: Role of glial cells in circadian clocks. Neuroreport 2002, 13, 2143–2147.
[CrossRef] [PubMed]
56. Yoo, S.H.; Yamazaki, S.; Lowrey, P.L.; Shimomura, K.; Ko, C.H.; Buhr, E.D.; Siepka, S.M.; Hong, H.K.; Oh, W.J.;
Yoo, O.J.; et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent
circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. USA 2004, 101, 5339–5346. [CrossRef]
[PubMed]
57. Balsalobre, A.; Damiola, F.; Schibler, U. A serum shock induces circadian gene expression in mammalian
tissue culture cells. Cell 1998, 93, 929–937. [CrossRef]
58. Brown, S.A.; Fleury-Olela, F.; Nagoshi, E.; Hauser, C.; Juge, C.; Meier, C.A.; Chicheportiche, R.; Dayer, J.M.;
Albrecht, U.; Schibler, U. The period length of fibroblast circadian gene expression varies widely among
human individuals. PLoS Biol. 2005, 3, e338. [CrossRef] [PubMed]
59. Nagoshi, E.; Brown, S.A.; Dibner, C.; Kornmann, B.; Schibler, U. Circadian gene expression in cultured cells.
Methods Enzymol. 2005, 393, 543–557. [PubMed]
60. Nagoshi, E.; Saini, C.; Bauer, C.; Laroche, T.; Naef, F.; Schibler, U. Circadian gene expression in individual
fibroblasts: Cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 2004, 119,
693–705. [CrossRef] [PubMed]
61. Yagita, K.; Tamanini, F.; van Der Horst, G.T.; Okamura, H. Molecular mechanisms of the biological clock in
cultured fibroblasts. Science 2001, 292, 278–281. [CrossRef] [PubMed]
62. Granados-Fuentes, D.; Saxena, M.T.; Prolo, L.M.; Aton, S.J.; Herzog, E.D. Olfactory bulb neurons express
functional, entrainable circadian rhythms. Eur. J. Neurosci. 2004, 19, 898–906. [CrossRef] [PubMed]
63. Granados-Fuentes, D.; Prolo, L.M.; Abraham, U.; Herzog, E.D. The suprachiasmatic nucleus entrains, but
does not sustain, circadian rhythmicity in the olfactory bulb. J. Neurosci. 2004, 24, 615–619. [CrossRef]
[PubMed]
64. Granados-Fuentes, D.; Tseng, A.; Herzog, E.D. A circadian clock in the olfactory bulb controls olfactory
responsivity. J. Neurosci. 2006, 26, 12219–12225. [CrossRef] [PubMed]
65. Yan, J.; Wang, H.; Liu, Y.; Shao, C. Analysis of gene regulatory networks in the mammalian circadian rhythm.
PLoS Comput. Biol. 2008, 4, e1000193. [CrossRef] [PubMed]
66. Hughes, M.E.; DiTacchio, L.; Hayes, K.R.; Vollmers, C.; Pulivarthy, S.; Baggs, J.E.; Panda, S.; Hogenesch, J.B.
Harmonics of circadian gene transcription in mammals. PLoS Genet. 2009, 5, e1000442. [CrossRef] [PubMed]
67. Akhtar, R.A.; Reddy, A.B.; Maywood, E.S.; Clayton, J.D.; King, V.M.; Smith, A.G.; Gant, T.W.; Hastings, M.H.;
Kyriacou, C.P. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven
by the suprachiasmatic nucleus. Curr. Biol. 2002, 12, 540–550. [CrossRef]
68. Ishida, A.; Mutoh, T.; Ueyama, T.; Bando, H.; Masubuchi, S.; Nakahara, D.; Tsujimoto, G.; Okamura, H.
Light activates the adrenal gland: Timing of gene expression and glucocorticoid release. Cell Metab. 2005, 2,
297–307. [CrossRef] [PubMed]
69. Kalsbeek, A.; Foppen, E.; Schalij, I.; Van Heijningen, C.; van der Vliet, J.; Fliers, E.; Buijs, R.M. Circadian
control of the daily plasma glucose rhythm: An interplay of GABA and glutamate. PLoS ONE 2008, 3, e3194.
[CrossRef] [PubMed]
70. Cailotto, C.; Lei, J.; van der Vliet, J.; van Heijningen, C.; van Eden, C.G.; Kalsbeek, A.; Pévet, P.; Buijs, R.M.
Effects of nocturnal light on (clock) gene expression in peripheral organs: A role for the autonomic
innervation of the liver. PLoS ONE 2009, 4, e5650. [CrossRef] [PubMed]
71. Vujovic, N.; Davidson, A.J.; Menaker, M. Sympathetic input modulates, but does not determine, phase of
peripheral circadian oscillators. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295, R355–R360. [CrossRef]
[PubMed]
72. Kornmann, B.; Schaad, O.; Bujard, H.; Takahashi, J.S.; Schibler, U. System-driven and oscillator-dependent
circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 2007, 5, e34. [CrossRef]
[PubMed]
73. Vollmers, C.; Gill, S.; DiTacchio, L.; Pulivarthy, S.R.; Le, H.D.; Panda, S. Time of feeding and the intrinsic
circadian clock drive rhythms in hepatic gene expression. Proc. Natl. Acad. Sci. USA 2009, 106, 21453–21458.
[CrossRef] [PubMed]
74. Strader, A.D.; Woods, S.C. Gastrointestinal hormones and food intake. Gastroenterology 2005, 128, 175–191.
[CrossRef] [PubMed]
Biology 2017, 6, 10 15 of 20
75. Buhr, E.D.; Yoo, S.H.; Takahashi, J.S. Temperature as a universal resetting cue for mammalian circadian
oscillators. Science 2010, 330, 379–385. [CrossRef] [PubMed]
76. Saini, C.; Morf, J.; Stratmann, M.; Gos, P.; Schibler, U. Simulated body temperature rhythms reveal the
phase-shifting behavior and plasticity of mammalian circadian oscillators. Genes Dev. 2012, 26, 567–580.
[CrossRef] [PubMed]
77. Lamia, K.A.; Storch, K.F.; Weitz, C.J. Physiological significance of a peripheral tissue circadian clock.
Proc. Natl. Acad. Sci. USA 2008, 105, 15172–15177. [CrossRef] [PubMed]
78. Balsalobre, A.; Brown, S.A.; Marcacci, L.; Tronche, F.; Kellendonk, C.; Reichardt, H.M.; Schütz, G.; Schibler, U.
Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000, 289, 2344–2347.
[CrossRef] [PubMed]
79. Englund, A.; Kovanen, L.; Saarikoski, S.T.; Haukka, J.; Reunanen, A.; Aromaa, A.; Lönnqvist, J.; Partonen, T.
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J. Circadian Rhythm. 2009, 7. [CrossRef]
[PubMed]
80. Le Martelot, G.; Claudel, T.; Gatfield, D.; Schaad, O.; Kornmann, B.; Lo Sasso, G.; Moschetta, A.; Schibler, U.
REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 2009, 7,
e1000181. [CrossRef] [PubMed]
81. Marcheva, B.; Ramsey, K.M.; Buhr, E.D.; Kobayashi, Y.; Su, H.; Ko, C.H.; Ivanova, G.; Omura, C.; Mo, S.;
Vitaterna, M.H.; Lopez, J.P.; et al. Disruption of the clock components CLOCK and BMAL1 leads to
hypoinsulinaemia and diabetes. Nature 2010, 466, 627–631. [CrossRef] [PubMed]
82. Sadacca, L.A.; Lamia, K.A.; deLemos, A.S.; Blum, B.; Weitz, C.J. An intrinsic circadian clock of the pancreas
is required for normal insulin release and glucose homeostasis in mice. Diabetologia 2011, 54, 120–124.
[CrossRef] [PubMed]
83. Zimmerman, N.H.; Menaker, M. The pineal gland: A pacemaker within the circadian system of the house
sparrow. Proc. Natl. Acad. Sci. USA 1979, 76, 999–1003. [CrossRef] [PubMed]
84. Gillette, M.U.; McArthur, A.J. Circadian actions of melatonin at the suprachiasmatic nucleus. Behav. Brain Res.
1996, 73, 135–139. [CrossRef]
85. Arendt, J.; Broadway, J. Light and melatonin as zeitgebers in man. Chronobiol. Int. 1987, 4, 273–282. [CrossRef]
[PubMed]
86. Armstrong, S.M.; Cassone, V.M.; Chesworth, M.J.; Redman, J.R.; Short, R.V. Synchronization of mammalian
circadian rhythms by melatonin. J. Neural Transm. Suppl. 1986, 21, 375–394. [PubMed]
87. Cassone, V.M.; Chesworth, M.J.; Armstrong, S.M. Entrainment of rat circadian rhythms by daily injection
of melatonin depends upon the hypothalamic suprachiasmatic nuclei. Physiol. Behav. 1986, 36, 1111–1121.
[CrossRef]
88. Cassone, V.M.; Chesworth, M.J.; Armstrong, S.M. Dose-dependent entrainment of rat circadian rhythms by
daily injection of melatonin. J. Biol. Rhythm. 1986, 1, 219–229. [CrossRef]
89. Redman, J.R.; Armstrong, S.M. Reentrainment of rat circadian activity rhythms: Effects of melatonin.
J. Pineal Res. 1988, 5, 203–215. [CrossRef] [PubMed]
90. Sack, R.L.; Brandes, R.W.; Kendall, A.R.; Lewy, A.J. Entrainment of free-running circadian rhythms by
melatonin in blind people. N. Engl. J. Med. 2000, 343, 1070–1077. [CrossRef] [PubMed]
91. Liu, C.; Weaver, D.R.; Jin, X.; Shearman, L.P.; Pieschl, R.L.; Gribkoff, V.K.; Reppert, S.M. Molecular dissection
of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997, 19, 91–102.
[CrossRef]
92. Shimomura, K.; Lowrey, P.L.; Vitaterna, M.H.; Buhr, E.D.; Kumar, V.; Hanna, P.; Omura, C.; Izumo, M.;
Low, S.S.; Barrett, R.K.; et al. Genetic suppression of the circadian Clock mutation by the melatonin
biosynthesis pathway. Proc. Natl. Acad. Sci. USA 2010, 107, 8399–8403. [CrossRef] [PubMed]
93. Hunt, A.E.; Al-Ghoul, W.M.; Gillette, M.U.; Dubocovich, M.L. Activation of MT(2) melatonin receptors
in rat suprachiasmatic nucleus phase advances the circadian clock. Am. J. Physiol. Cell Physiol. 2001, 280,
C110–C118. [PubMed]
94. Campino, C.; Valenzuela, F.J.; Torres-Farfan, C.; Reynolds, H.E.; Abarzua-Catalan, L.; Arteaga, E.; Trucco, C.;
Guzmán, S.; Valenzuela, G.J.; Seron-Ferre, M. Melatonin exerts direct inhibitory actions on ACTH responses
in the human adrenal gland. Horm. Metab. Res. 2011, 43, 337–342. [CrossRef] [PubMed]
Biology 2017, 6, 10 16 of 20
95. Torres-Farfan, C.; Richter, H.G.; Germain, A.M.; Valenzuela, G.J.; Campino, C.; Rojas-García, P.; Forcelledo, M.L.;
Torrealba, F.; Serón-Ferré, M. Maternal melatonin selectively inhibits cortisol production in the primate fetal
adrenal gland. J. Physiol. 2004, 554 Pt 3, 841–856. [CrossRef] [PubMed]
96. Torres-Farfan, C.; Richter, H.G.; Rojas-García, P.; Vergara, M.; Forcelledo, M.L.; Valladares, L.E.; Torrealba, F.;
Valenzuela, G.J.; Serón-Ferré, M. mt1 Melatonin receptor in the primate adrenal gland: Inhibition of
adrenocorticotropin-stimulated cortisol production by melatonin. J. Clin. Endocrinol. Metab. 2003, 88,
450–458. [CrossRef] [PubMed]
97. Torres-Farfan, C.; Mendez, N.; Abarzua-Catalan, L.; Vilches, N.; Valenzuela, G.J.; Seron-Ferre, M. A circadian
clock entrained by melatonin is ticking in the rat fetal adrenal. Endocrinology 2011, 152, 1891–1900. [CrossRef]
[PubMed]
98. Pandi-Perumal, S.R.; Srinivasan, V.; Maestroni, G.J.; Cardinali, D.P.; Poeggeler, B.; Hardeland, R. Melatonin:
Nature’s most versatile biological signal? FEBS J. 2006, 273, 2813–2838. [CrossRef] [PubMed]
99. Reppert, S.M.; Weaver, D.R. Melatonin madness. Cell 1995, 83, 1059–1062. [CrossRef]
100. Scheer, F.A.; Van Montfrans, G.A.; van Someren, E.J.; Mairuhu, G.; Buijs, R.M. Daily nighttime melatonin
reduces blood pressure in male patients with essential hypertension. Hypertension 2004, 43, 192–197.
[CrossRef] [PubMed]
101. Mills, E.; Wu, P.; Seely, D.; Guyatt, G. Melatonin in the treatment of cancer: A systematic review of
randomized controlled trials and meta-analysis. J. Pineal Res. 2005, 39, 360–366. [CrossRef] [PubMed]
102. Barnes, P.M.; Bloom, B.; Nahin, R.L. Complementary and alternative medicine use among adults and
children: United States, 2007. Natl. Health Stat. Rep. 2008, 12, 1–23.
103. Gansler, T.; Kaw, C.; Crammer, C.; Smith, T. A population-based study of prevalence of complementary
methods use by cancer survivors: A report from the American Cancer Society’s studies of cancer survivors.
Cancer 2008, 113, 1048–1057. [CrossRef] [PubMed]
104. Schwartz, W.J.; Reppert, S.M. Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid:
A pre-eminent role for the suprachiasmatic nuclei. J. Neurosci. 1985, 5, 2771–2778. [PubMed]
105. Kametani, H.; Kawamura, H. Circadian rhythm of cortical acetylcholine release as measured by in vivo
microdialysis in freely moving rats. Neurosci. Lett. 1991, 132, 263–266. [CrossRef]
106. Hut, R.A.; van der Zee, E.A. The cholinergic system, circadian rhythmicity, and time memory. Behav. Brain Res.
2011, 221, 466–480. [CrossRef] [PubMed]
107. Buijs, R.M.; Wortel, J.; Van Heerikhuize, J.J.; Feenstra, M.G.; Ter Horst, G.J.; Romijn, H.J.; Kalsbeek, A.
Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex)
pathway. Eur. J. Neurosci. 1999, 11, 1535–1544. [CrossRef] [PubMed]
108. Oster, H.; Damerow, S.; Hut, R.A.; Eichele, G. Transcriptional profiling in the adrenal gland reveals circadian
regulation of hormone biosynthesis genes and nucleosome assembly genes. J. Biol. Rhythm. 2006, 21, 350–361.
[CrossRef] [PubMed]
109. Oster, H.; Damerow, S.; Kiessling, S.; Jakubcakova, V.; Abraham, D.; Tian, J.; Hoffmann, M.W.; Eichele, G.
The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical
clock. Cell Metab. 2006, 4, 163–173. [CrossRef] [PubMed]
110. Oster, H. The genetic basis of circadian behavior. Genes Brain Behav. 2006, 5, 73–79. [CrossRef] [PubMed]
111. Reddy, A.B.; Maywood, E.S.; Karp, N.A.; King, V.M.; Inoue, Y.; Gonzalez, F.J.; Lilley, K.S.; Kyriacou, C.P.;
Hastings, M.H. Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology 2007, 45,
1478–1488. [CrossRef] [PubMed]
112. Yamazaki, S.; Numano, R.; Abe, M.; Hida, A.; Takahashi, R.; Ueda, M.; Block, G.D.; Sakaki, Y.; Menaker, M.;
Tei, H. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000, 288, 682–685.
[CrossRef] [PubMed]
113. Dickmeis, T. Glucocorticoids and the circadian clock. J. Endocrinol. 2009, 200, 3–22. [CrossRef] [PubMed]
114. Kalsbeek, A.; van Heerikhuize, J.J.; Wortel, J.; Buijs, R.M. A diurnal rhythm of stimulatory input to the
hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the
vasopressin V1 antagonist. J. Neurosci. 1996, 16, 5555–5565. [PubMed]
115. Dijk, D.J.; Duffy, J.F.; Silva, E.J.; Shanahan, T.L.; Boivin, D.B.; Czeisler, C.A. Amplitude reduction and phase
shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure
in humans. PLoS ONE 2012, 7, e30037. [CrossRef] [PubMed]
Biology 2017, 6, 10 17 of 20
116. Doane, L.D.; Kremen, W.S.; Eaves, L.J.; Eisen, S.A.; Hauger, R.; Hellhammer, D.; Levine, S.; Lupien, S.;
Lyons, M.J.; Mendoza, S.; et al. Associations between jet lag and cortisol diurnal rhythms after domestic
travel. Health Psychol. 2010, 29, 117–123. [CrossRef] [PubMed]
117. Carroll, T.B.; Findling, J.W. The diagnosis of Cushing’s syndrome. Rev. Endocr. Metab. Disord. 2010, 11,
147–153. [CrossRef] [PubMed]
118. Antoni, M.H.; Lutgendorf, S.K.; Cole, S.W.; Dhabhar, F.S.; Sephton, S.E.; McDonald, P.G.; Stefanek, M.;
Sood, A.K. The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nat. Rev.
Cancer 2006, 6, 240–248. [CrossRef] [PubMed]
119. Thaker, P.H.; Han, L.Y.; Kamat, A.A.; Arevalo, J.M.; Takahashi, R.; Lu, C.; Jennings, N.B.; Armaiz-Pena, G.;
Bankson, J.A.; Ravoori, M.; et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model
of ovarian carcinoma. Nat. Med. 2006, 12, 939–944. [CrossRef] [PubMed]
120. Gomez-Abellan, P.; Díez-Noguera, A.; Madrid, J.A.; Luján, J.A.; Ordovás, J.M.; Garaulet, M. Glucocorticoids
affect 24 h clock genes expression in human adipose tissue explant cultures. PLoS ONE 2012, 7, e50435.
[CrossRef] [PubMed]
121. Pezuk, P.; Mohawk, J.A.; Wang, L.A.; Menaker, M. Glucocorticoids as entraining signals for peripheral
circadian oscillators. Endocrinology 2012, 153, 4775–4783. [CrossRef] [PubMed]
122. Kiessling, S.; Eichele, G.; Oster, H. Adrenal glucocorticoids have a key role in circadian resynchronization in
a mouse model of jet lag. J. Clin. Investig. 2010, 120, 2600–2609. [CrossRef] [PubMed]
123. Su, Y.; Cailotto, C.; Foppen, E.; Jansen, R.; Zhang, Z.; Buijs, R.; Fliers, E.; Kalsbeek, A. The role of feeding
rhythm, adrenal hormones and neuronal inputs in synchronizing daily clock gene rhythms in the liver.
Mol. Cell. Endocrinol. 2016, 422, 125–131. [CrossRef] [PubMed]
124. Barclay, J.L.; Shostak, A.; Leliavski, A.; Tsang, A.H.; Jöhren, O.; Müller-Fielitz, H.; Landgraf, D.; Naujokat, N.;
van der Horst, G.T.; Oster, H. High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance
in Cry-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304, E1053–E1063. [CrossRef] [PubMed]
125. Zhao, Y.; Zhang, Y.; Zhou, M.; Wang, S.; Hua, Z.; Zhang, J. Loss of mPer2 increases plasma insulin levels by
enhanced glucose-stimulated insulin secretion and impaired insulin clearance in mice. FEBS Lett. 2012, 586,
1306–1311. [CrossRef] [PubMed]
126. Esquirol, Y.; Bongard, V.; Ferrieres, J.; Verdier, H.; Perret, B. Shiftwork and higher pancreatic secretion: Early
detection of an intermediate state of insulin resistance? Chronobiol. Int. 2012, 29, 1258–1266. [CrossRef]
[PubMed]
127. Tucker, P.; Marquié, J.C.; Folkard, S.; Ansiau, D.; Esquirol, Y. Shiftwork and metabolic dysfunction.
Chronobiol. Int. 2012, 29, 549–555. [CrossRef] [PubMed]
128. Tahara, Y.; Otsuka, M.; Fuse, Y.; Hirao, A.; Shibata, S. Refeeding after fasting elicits insulin-dependent
regulation of Per2 and Rev-erbalpha with shifts in the liver clock. J. Biol. Rhythm. 2011, 26, 230–240.
[CrossRef] [PubMed]
129. Yamajuku, D.; Inagaki, T.; Haruma, T.; Okubo, S.; Kataoka, Y.; Kobayashi, S.; Ikegami, K.; Laurent, T.;
Kojima, T.; Noutomi, K.; et al. Real-time monitoring in three-dimensional hepatocytes reveals that insulin
acts as a synchronizer for liver clock. Sci. Rep. 2012, 2, 439. [CrossRef] [PubMed]
130. Hirota, T.; Okano, T.; Kokame, K.; Shirotani-Ikejima, H.; Miyata, T.; Fukada, Y. Glucose down-regulates Per1
and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J. Biol. Chem.
2002, 277, 44244–44251. [CrossRef] [PubMed]
131. LeSauter, J.; Hoque, N.; Weintraub, M.; Pfaff, D.W.; Silver, R. Stomach ghrelin-secreting cells as
food-entrainable circadian clocks. Proc. Natl. Acad. Sci. USA 2009, 106, 13582–13587. [CrossRef] [PubMed]
132. Abizaid, A.; Liu, Z.W.; Andrews, Z.B.; Shanabrough, M.; Borok, E.; Elsworth, J.D.; Roth, R.H.; Sleeman, M.W.;
Picciotto, M.R.; Tschöp, M.H.; et al. Ghrelin modulates the activity and synaptic input organization of
midbrain dopamine neurons while promoting appetite. J. Clin. Investig. 2006, 116, 3229–3239. [CrossRef]
[PubMed]
133. Date, Y.; Shimbara, T.; Koda, S.; Toshinai, K.; Ida, T.; Murakami, N.; Miyazato, M.; Kokame, K.; Ishizuka, Y.;
Ishida, Y.; et al. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the
hindbrain to the hypothalamus. Cell Metab. 2006, 4, 323–331. [CrossRef] [PubMed]
134. Toshinai, K.; Yamaguchi, H.; Sun, Y.; Smith, R.G.; Yamanaka, A.; Sakurai, T.; Date, Y.; Mondal, M.S.;
Shimbara, T.; Kawagoe, T.; et al. Des-acyl ghrelin induces food intake by a mechanism independent of the
growth hormone secretagogue receptor. Endocrinology 2006, 147, 2306–2314. [CrossRef] [PubMed]
Biology 2017, 6, 10 18 of 20
135. Schiavo-Cardozo, D.; Lima, M.M.; Pareja, J.C.; Geloneze, B. Appetite-regulating hormones from the upper
gut: Disrupted control of xenin and ghrelin in night workers. Clin. Endocrinol. 2013, 79, 807–811. [CrossRef]
[PubMed]
136. Yannielli, P.C.; Molyneux, P.C.; Harrington, M.E.; Golombek, D.A. Ghrelin effects on the circadian system of
mice. J. Neurosci. 2007, 27, 2890–2895. [CrossRef] [PubMed]
137. Gavrila, A.; Peng, C.K.; Chan, J.L.; Mietus, J.E.; Goldberger, A.L.; Mantzoros, C.S. Diurnal and ultradian
dynamics of serum adiponectin in healthy men: Comparison with leptin, circulating soluble leptin receptor,
and cortisol patterns. J. Clin. Endocrinol. Metab. 2003, 88, 2838–2843. [CrossRef] [PubMed]
138. Scheer, F.A.; Chan, J.L.; Fargnoli, J.; Chamberland, J.; Arampatzi, K.; Shea, S.A.; Blackburn, G.L.;
Mantzoros, C.S. Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy
men studied under fed and fasted conditions. Diabetologia 2010, 53, 2401–2405. [CrossRef] [PubMed]
139. Harwood, H.J., Jr. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis.
Neuropharmacology 2012, 63, 57–75. [CrossRef] [PubMed]
140. Hu, E.; Liang, P.; Spiegelman, B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity.
J. Biol. Chem. 1996, 271, 10697–10703. [PubMed]
141. Yang, W.S.; Lee, W.J.; Funahashi, T.; Tanaka, S.; Matsuzawa, Y.; Chao, C.L.; Chen, C.L.; Tai, T.Y.; Chuang, L.M.
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.
J. Clin. Endocrinol. Metab. 2001, 86, 3815–3819. [CrossRef] [PubMed]
142. Barnea, M.; Shamay, A.; Stark, A.H.; Madar, Z. A high-fat diet has a tissue-specific effect on adiponectin and
related enzyme expression. Obesity 2006, 14, 2145–2153. [CrossRef] [PubMed]
143. Bullen, J.W., Jr.; Bluher, S.; Kelesidis, T.; Mantzoros, C.S. Regulation of adiponectin and its receptors in
response to development of diet-induced obesity in mice. Am. J. Physiol. Endocrinol. Metab. 2007, 292,
E1079–E1086. [CrossRef] [PubMed]
144. Hashinaga, T.; Wada, N.; Otabe, S.; Yuan, X.; Kurita, Y.; Kakino, S.; Tanaka, K.; Sato, T.; Kojima, M.; Ohki, T.;
Nakayama, H.; et al. Modulation by adiponectin of circadian clock rhythmicity in model mice for metabolic
syndrome. Endocr. J. 2013, 60, 483–492. [CrossRef] [PubMed]
145. Gautron, L.; Elmquist, J.K. Sixteen years and counting: An update on leptin in energy balance. J. Clin. Investig.
2011, 121, 2087–2093. [CrossRef] [PubMed]
146. Mendoza, J.; Lopez-Lopez, C.; Revel, F.G.; Jeanneau, K.; Delerue, F.; Prinssen, E.; Challet, E.; Moreau, J.L.;
Grundschober, C. Dimorphic effects of leptin on the circadian and hypocretinergic systems of mice.
J. Neuroendocrinol. 2011, 23, 28–38. [CrossRef] [PubMed]
147. Prosser, R.A.; Bergeron, H.E. Leptin phase-advances the rat suprachiasmatic circadian clock in vitro.
Neurosci. Lett. 2003, 336, 139–142. [CrossRef]
148. Eckel-Mahan, K.L.; Patel, V.R.; Mohney, R.P.; Vignola, K.S.; Baldi, P.; Sassone-Corsi, P. Coordination of the
transcriptome and metabolome by the circadian clock. Proc. Natl. Acad. Sci. USA 2012, 109, 5541–5546.
[CrossRef] [PubMed]
149. Kasukawa, T.; Sugimoto, M.; Hida, A.; Minami, Y.; Mori, M.; Honma, S.; Honma, K.; Mishima, K.; Soga, T.;
Ueda, H.R. Human blood metabolite timetable indicates internal body time. Proc. Natl. Acad. Sci. USA 2012,
109, 15036–15041. [CrossRef] [PubMed]
150. Minami, Y.; Kasukawa, T.; Kakazu, Y.; Iigo, M.; Sugimoto, M.; Ikeda, S.; Yasui, A.; van der Horst, G.T.;
Soga, T.; Ueda, H.R. Measurement of internal body time by blood metabolomics. Proc. Natl. Acad. Sci. USA
2009, 106, 9890–9895. [CrossRef] [PubMed]
151. Chalkiadaki, A.; Guarente, L. Sirtuins mediate mammalian metabolic responses to nutrient availability.
Nat. Rev. Endocrinol. 2012, 8, 287–296. [CrossRef] [PubMed]
152. Belden, W.J.; Dunlap, J.C. SIRT1 is a circadian deacetylase for core clock components. Cell 2008, 134, 212–214.
[CrossRef] [PubMed]
153. Nakahata, Y.; Kaluzova, M.; Grimaldi, B.; Sahar, S.; Hirayama, J.; Chen, D.; Guarente, L.P.; Sassone-Corsi, P.
The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian
control. Cell 2008, 134, 329–340. [CrossRef] [PubMed]
154. Nakahata, Y.; Sahar, S.; Astarita, G.; Kaluzova, M.; Sassone-Corsi, P. Circadian control of the NAD+ salvage
pathway by CLOCK-SIRT1. Science 2009, 324, 654–657. [CrossRef] [PubMed]
Biology 2017, 6, 10 19 of 20
155. Asher, G.; Gatfield, D.; Stratmann, M.; Reinke, H.; Dibner, C.; Kreppel, F.; Mostoslavsky, R.; Alt, F.W.;
Schibler, U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134,
317–328. [CrossRef] [PubMed]
156. Chang, H.C.; Guarente, L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays
with aging. Cell 2013, 153, 1448–1460. [CrossRef] [PubMed]
157. Lamia, K.A.; Sachdeva, U.M.; DiTacchio, L.; Williams, E.C.; Alvarez, J.G.; Egan, D.F.; Vasquez, D.S.;
Juguilon, H.; Panda, S.; Shaw, R.J.; et al. AMPK regulates the circadian clock by cryptochrome phosphorylation
and degradation. Science 2009, 326, 437–440. [CrossRef] [PubMed]
158. Rudic, R.D.; McNamara, P.; Curtis, A.M.; Boston, R.C.; Panda, S.; Hogenesch, J.B.; Fitzgerald, G.A. BMAL1
and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol.
2004, 2, e377. [CrossRef] [PubMed]
159. Zhang, E.E.; Liu, Y.; Dentin, R.; Pongsawakul, P.Y.; Liu, A.C.; Hirota, T.; Nusinow, D.A.; Sun, X.;
Landais, S.; Kodama, Y.; et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic
gluconeogenesis. Nat. Med. 2010, 16, 1152–1156. [CrossRef] [PubMed]
160. Yin, L.; Wu, N.; Curtin, J.C.; Qatanani, M.; Szwergold, N.R.; Reid, R.A.; Waitt, G.M.; Parks, D.J.; Pearce, K.H.;
Wisely, G.B.; et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science
2007, 318, 1786–1789. [CrossRef] [PubMed]
161. Solt, L.A.; Wang, Y.; Banerjee, S.; Hughes, T.; Kojetin, D.J.; Lundasen, T.; Shin, Y.; Liu, J.; Cameron, M.D.;
Noel, R.; Yoo, S.H.; et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.
Nature 2012, 485, 62–68. [CrossRef] [PubMed]
162. Hirota, T.; Lewis, W.G.; Liu, A.C.; Lee, J.W.; Schultz, P.G.; Kay, S.A. A chemical biology approach reveals
period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc. Natl. Acad.
Sci. USA 2008, 105, 20746–20751. [CrossRef] [PubMed]
163. Cambras, T.; Weller, J.R.; Anglès-Pujoràs, M.; Lee, M.L.; Christopher, A.; Díez-Noguera, A.; Krueger, J.M.; de
la Iglesia, H.O. Circadian desynchronization of core body temperature and sleep stages in the rat. Proc. Natl.
Acad. Sci. USA 2007, 104, 7634–7639. [CrossRef] [PubMed]
164. Castanon-Cervantes, O.; Wu, M.; Ehlen, J.C.; Paul, K.; Gamble, K.L.; Johnson, R.L.; Besing, R.C.; Menaker, M.;
Gewirtz, A.T.; Davidson, A.J. Dysregulation of inflammatory responses by chronic circadian disruption.
J. Immunol. 2010, 185, 5796–5805. [CrossRef] [PubMed]
165. Filipski, E.; Subramanian, P.; Carrière, J.; Guettier, C.; Barbason, H.; Lévi, F. Circadian disruption accelerates
liver carcinogenesis in mice. Mutat. Res. 2009, 680, 95–105. [CrossRef] [PubMed]
166. Tsai, L.L.; Tsai, Y.C.; Hwang, K.; Huang, Y.W.; Tzeng, J.E. Repeated light-dark shifts speed up body weight
gain in male F344 rats. Am. J. Physiol. Endocrinol. Metab. 2005, 289, E212–E217. [CrossRef] [PubMed]
167. Bellastella, A.; Pisano, G.; Iorio, S.; Pasquali, D.; Orio, F.; Venditto, T.; Sinisi, A.A. Endocrine secretions under
abnormal light-dark cycles and in the blind. Horm. Res. 1998, 49, 153–157. [CrossRef] [PubMed]
168. De la Iglesia, H.O.; Cambras, T.; Schwartz, W.J.; Díez-Noguera, A. Forced desynchronization of dual circadian
oscillators within the rat suprachiasmatic nucleus. Curr. Biol. 2004, 14, 796–800. [CrossRef] [PubMed]
169. Scheer, F.A.; Hilton, M.F.; Mantzoros, C.S.; Shea, S.A. Adverse metabolic and cardiovascular consequences of
circadian misalignment. Proc. Natl. Acad. Sci. USA 2009, 106, 4453–4458. [CrossRef] [PubMed]
170. Leproult, R.; Holmback, U.; van Cauter, E. Circadian misalignment augments markers of insulin resistance
and inflammation, independently of sleep loss. Diabetes 2014, 63, 1860–1869. [CrossRef] [PubMed]
171. Hirota, T.; Lee, J.W.; St John, P.C.; Sawa, M.; Iwaisako, K.; Noguchi, T.; Pongsawakul, P.Y.; Sonntag, T.;
Welsh, D.K.; Brenner, D.A.; et al. Identification of small molecule activators of cryptochrome. Science 2012,
337, 1094–1097. [CrossRef] [PubMed]
172. Hirota, T.; Lee, J.W.; Lewis, W.G.; Zhang, E.E.; Breton, G.; Liu, X.; Garcia, M.; Peters, E.C.; Etchegaray, J.P.;
Traver, D.; et al. High-throughput chemical screen identifies a novel potent modulator of cellular circadian
rhythms and reveals CKIalpha as a clock regulatory kinase. PLoS Biol. 2010, 8, e1000559. [CrossRef]
[PubMed]
173. Geerdink, M.; Walbeek, T.J.; Beersma, D.G.; Hommes, V.; Gordijn, M.C. Short Blue Light Pulses (30 Min)
in the Morning Support a Sleep-Advancing Protocol in a Home Setting. J. Biol. Rhythm. 2016, 31, 483–497.
[CrossRef] [PubMed]
174. Najjar, R.P.; Zeitzer, J.M. Temporal integration of light flashes by the human circadian system. J. Clin. Investig.
2016, 126, 938–947. [CrossRef] [PubMed]
Biology 2017, 6, 10 20 of 20
175. Hermida, R.C.; Ayala, D.E.; Fernández, J.R.; Portaluppi, F.; Fabbian, F.; Smolensky, M.H. Circadian rhythms
in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB
medications. Am. J. Hypertens. 2011, 24, 383–391. [CrossRef] [PubMed]
176. Hermida, R.C.; Ayala, D.E.; Smolensky, M.H.; Fernández, J.R.; Mojón, A.; Portaluppi, F. Chronotherapy with
conventional blood pressure medications improves management of hypertension and reduces cardiovascular
and stroke risks. Hypertens. Res. 2016, 39, 277–292. [CrossRef] [PubMed]
177. Portaluppi, F.; Smolensky, M.H. Perspectives on the chronotherapy of hypertension based on the results of
the MAPEC study. Chronobiol. Int. 2010, 27, 1652–1667. [CrossRef] [PubMed]
178. Smolensky, M.H.; Hermida, R.C.; Ayala, D.E.; Tiseo, R.; Portaluppi, F. Administration-time-dependent effects
of blood pressure-lowering medications: Basis for the chronotherapy of hypertension. Blood Press. Monit.
2010, 15, 173–180. [CrossRef] [PubMed]
179. Stranges, P.M.; Drew, A.M.; Rafferty, P.; Shuster, J.E.; Brooks, A.D. Treatment of hypertension with
chronotherapy: Is it time of drug administration? Ann. Pharmacother. 2015, 49, 323–334. [CrossRef]
[PubMed]
180. Buttgereit, F.; Doering, G.; Schaeffler, A.; Witte, S.; Sierakowski, S.; Gromnica-Ihle, E.; Jeka, S.; Krueger, K.;
Szechinski, J.; Alten, R. Efficacy of modified-release versus standard prednisone to reduce duration of
morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): A double-blind, randomised controlled
trial. Lancet 2008, 371, 205–214. [CrossRef]
181. Haspel, J.A.; Chettimada, S.; Shaik, R.S.; Chu, J.H.; Raby, B.A.; Cernadas, M.; Carey, V.; Process, V.;
Hunninghake, G.M.; Ifedigbo, E.; et al. Circadian rhythm reprogramming during lung inflammation.
Nat. Commun. 2014, 5, 4753. [CrossRef] [PubMed]
182. Narasimamurthy, R.; Hatori, M.; Nayak, S.K.; Liu, F.; Panda, S.; Verma, I.M. Circadian clock protein
cryptochrome regulates the expression of proinflammatory cytokines. Proc. Natl. Acad. Sci. USA 2012, 109,
12662–12667. [CrossRef] [PubMed]
183. Bunney, B.G.; Li, J.Z.; Walsh, D.M.; Stein, R.; Vawter, M.P.; Cartagena, P.; Barchas, J.D.; Schatzberg, A.F.;
Myers, R.M.; Watson, S.J.; et al. Circadian dysregulation of clock genes: Clues to rapid treatments in major
depressive disorder. Mol. Psychiatry 2015, 20, 48–55. [CrossRef] [PubMed]
184. Levi, F. Circadian chronotherapy for human cancers. Lancet Oncol. 2001, 2, 307–315. [CrossRef]
185. Ortiz-Tudela, E.; Mteyrek, A.; Ballesta, A.; Innominato, P.F.; Lévi, F. Cancer chronotherapeutics: Experimental,
theoretical, and clinical aspects. Handb. Exp. Pharmacol. 2013, 217, 261–288.
© 2017 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
